Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၇၇%
၁,၀၉၇.၈၁
-၈.၅၅
-၀.၇၇%
—၁,၁၀၆.၃၆၁,၁၀၅.၆၈၁,၁၀၉.၂၉၁,၀၉၆.၅၂——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၉%
၆၁၂.၀၃
+၁.၇၄
+၀.၂၉%
—၆၁၀.၂၉၆၁၀.၂၉၆၁၆.၆၀၆၁၀.၂၉——
SIXE
Energy
SIXE
Energy
SIXE
+၀.၇၆%
၁,၂၂၀.၄၃
+၉.၂၁
+၀.၇၆%
—၁,၂၁၁.၂၂၁,၂၁၁.၀၁၁,၂၂၂.၃၆၁,၂၀၈.၅၀——
SIXI
Industrials
SIXI
Industrials
SIXI
+၀.၅၀%
၁,၇၅၉.၅၂
+၈.၈၁
+၀.၅၀%
—၁,၇၅၀.၇၁၁,၇၅၃.၁၀၁,၇၆၂.၁၃၁,၇၄၃.၃၀——
SIXM
Financials
SIXM
Financials
SIXM
+၀.၅၄%
၆၃၁.၅၄
+၃.၃၇
+၀.၅၄%
—၆၂၈.၁၇၆၂၉.၃၈၆၃၄.၀၉၆၂၉.၃၈——
SIXR
Staples
SIXR
Staples
SIXR
+၀.၃၀%
၈၅၇.၁၆
+၂.၅၉
+၀.၃၀%
—၈၅၄.၅၇၈၅၅.၇၁၈၆၀.၀၉၈၅၅.၄၅——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၆၇%
၂၁၅.၄၁
-၁.၄၆
-၀.၆၇%
—၂၁၆.၈၇၂၁၆.၈၇၂၁၇.၇၉၂၁၅.၂၉——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၄၇%
၃,၆၁၄.၁၅
+၅၂.၂၁
+၁.၄၇%
—၃,၅၆၁.၉၄၃,၅၇၁.၄၄၃,၆၂၈.၅၈၃,၅၆၂.၁၅——
SIXU
Utilities
SIXU
Utilities
SIXU
+၀.၅၅%
၉၀၈.၃၀
+၄.၉၉
+၀.၅၅%
—၉၀၃.၃၁၉၀၃.၂၆၉၀၈.၃၈၉၀၁.၁၈——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၀၈%
၁,၄၈၀.၄၀
-၁.၁၄
-၀.၀၈%
—၁,၄၈၁.၅၄၁,၄၈၂.၄၈၁,၄၈၈.၄၆၁,၄၇၄.၁၈——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၀.၀၇%
၂,၃၉၈.၃၇
-၁.၅၈
-၀.၀၇%
—၂,၃၉၉.၉၅၂,၄၀၄.၄၅၂,၄၁၈.၈၁၂,၃၉၆.၀၄——
ARCT:NASDAQ
Arcturus Therapeutics Holdings Inc
၇.၈၃ US$
-၅.၂၁%
(-၀.၄၃) 1D
၈.၂၀ US$
+၄.၇၃% (+၀.၃၇)
After hours
Closed: မေ ၁၄, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARCT...
Open
၈.၃၉ US$
High
၈.၅၃ US$
Low
၇.၈၀ US$
Mkt. cap
၂၂.၂၆ ကုဋေ
Avg. vol.
၄.၁၄ သိန်း
Volume
၅.၂၂ သိန်း
52-wk high
၂၄.၁၄ US$
52-wk low
၅.၈၆ US$
EPS
-၂.၈၂ US$
Beta
၂.၄၃
Shares outstanding
၂.၈၄ ကုဋေ
No. of employees
၁၀၉
News stories
From sources across the web
InvestmentNews
InvestmentNews
·
ပြီးခဲ့သည့် ၁၃ မိနစ်
Cerebras IPO explodes onto Nasdaq as AI chip frenzy mints billionaires, but is SpaceX next?
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
Insider Buying: Pool (NASDAQ:POOL) Director Buys 10,000 Shares of Stock
Nasdaq
Nasdaq
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
Assets and Liquidity in the Nasdaq-100 Ecosystem
Los Angeles Times
Los Angeles Times
·
ပြီးခဲ့သည့် ၁ နာရီ
Cisco leads Wall Street to more records and the Dow back to 50,000
Profile
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA. The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025. Wikipedia
About Arcturus Therapeutics Holdings Inc
CEOJoseph E. Payne
Employees၁၀၉
Founded၂၀၁၃
Headquarters-
Sector-
Websitearcturusrx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၂.၈၃ ကုဋေ
၁.၇၂ ကုဋေ
၇.၂၀ သန်း
၂.၀၆ သန်း
Cost of goods sold
၂.၉၆ ကုဋေ
၂.၃၃ ကုဋေ
၂.၄၅ ကုဋေ
၂.၁၅ ကုဋေ
Cost of revenue
၂.၉၆ ကုဋေ
၂.၃၃ ကုဋေ
၂.၄၅ ကုဋေ
၂.၁၅ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၀၃ ကုဋေ
၁.၀၄ ကုဋေ
၁.၄၀ ကုဋေ
၉.၄၆ သန်း
Operating expense
၁.၀၃ ကုဋေ
၁.၀၄ ကုဋေ
၁.၄၀ ကုဋေ
၉.၄၆ သန်း
Total operating expenses
၃.၉၉ ကုဋေ
၃.၃၇ ကုဋေ
၃.၈၅ ကုဋေ
၃.၁၀ ကုဋေ
Operating income
-၁.၁၆ ကုဋေ
-၁.၆၅ ကုဋေ
-၃.၁၃ ကုဋေ
-၂.၈၉ ကုဋေ
Other non operating income
-
-
-
၃.၅၀ သောင်း
EBT including unusual items
-၉.၁၈ သန်း
-၁.၃၄ ကုဋေ
-၂.၉၁ ကုဋေ
-၂.၇၀ ကုဋေ
EBT excluding unusual items
-၉.၁၈ သန်း
-၁.၃၄ ကုဋေ
-၂.၉၁ ကုဋေ
-၂.၇၀ ကုဋေ
Income tax expense
၄.၀၀ ထောင်
-
-၄.၀၀ ထောင်
-
Effective tax rate
-၀.၀၄%
-
၀.၀၁%
-
Other operating expenses
-
-
-
-
Net income
-၉.၁၈ သန်း
-၁.၃၄ ကုဋေ
-၂.၉၁ ကုဋေ
-၂.၇၀ ကုဋေ
Net profit margin
-၃၂.၄၄%
-၇၈.၄၁%
-၄၀၄.၁၀%
-၁,၃၀၈.၃၀%
Earnings per share
-၀.၃၄
-၀.၄၉
-၁.၀၃
-၀.၉၅
Interest and investment income
၂.၅၇ သန်း
၃.၂၃ သန်း
၁.၅၃ သန်း
၁.၉၃ သန်း
Interest expense
-
-
-၉.၀၀ ထောင်
-
Net interest expenses
၂.၅၇ သန်း
၃.၂၃ သန်း
၁.၅၂ သန်း
၁.၉၃ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၈ ကုဋေ
-၁.၅၇ ကုဋေ
-၃.၀၆ ကုဋေ
-၂.၈၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-၃.၄၀ သောင်း
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer